A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

NCT07395687 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

333

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: UBT251
DRUG: Placebo

Sponsor

Novo Nordisk A/S